Browse by Title

Type here to filter the list

L
Large-scale empirical identification of candidate comparators for pharmacoepidemiological studies

Justin Bohn, ScD – Johnson & Johnson ### 1991161###Presenting Author###Associate Director, Epidemiology###Johnson & Johnson###
Presenting Author: Justin Bohn, ScD – Johnson & Johnson
### @@@ James P. Gilbert, PhD – Janssen Research & Development ### 1659757###Co-Author###Manager of Epidemiology Analytics###Janssen Research & Development###
Co-Author: James P. Gilbert, PhD – Janssen Research & Development
### @@@ Christopher Knoll – Johnson & Johnson ### 1991162###Co-Author######Johnson & Johnson###
Co-Author: Christopher Knoll – Johnson & Johnson
### @@@ David M. Kern, PhD, MS – Janssen Research & Development ### 1062834###Co-Author###Sr. Director, Epidemiology###Janssen Research & Development###
Co-Author: David M. Kern, PhD, MS – Janssen Research & Development
### @@@ Patrick B. Ryan, PhD – Johnson & Johnson ### 1661016###Co-Author######Johnson & Johnson###
Co-Author: Patrick B. Ryan, PhD – Johnson & Johnson
###
Let Us Give it a Trial: Methods in PE

Jessica M. Franklin, PhD (she/her/hers) – Optum Epidemiology ### 1359343###Co-Moderator###Principal Consultant, Real-World Evidence###Optum Epidemiology###
Co-Moderator: Jessica M. Franklin, PhD (she/her/hers) – Optum Epidemiology
### she/her/hers @@@ Soko Setoguchi, MD, DrPH, FISPE – Department of Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ ### 1302720###Co-Moderator###Professor of Medicine and Epidemiology###Department of Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ###
Co-Moderator: Soko Setoguchi, MD, DrPH, FISPE – Department of Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ
###
Leveraging Real-World Insights to Inform Long-term Follow-up for Cell and Gene Therapies: Opportunities for Pharmacoepidemiologists

Jamie Geier, PhD (she/her/hers) – Novartis ### 1991591###Lead Speaker###Global Head, Quantitative Safety & Epidemiology###Novartis###
Lead Speaker: Jamie Geier, PhD (she/her/hers) – Novartis
### she/her/hers @@@ Kui Huang, PhD, MPH – Pfizer, Inc. ### 1359236###Speaker###Senior Director###Pfizer, Inc.###
Speaker: Kui Huang, PhD, MPH – Pfizer, Inc.
### @@@ Emily W. Bratton, MSPH, PhD (she/her/hers) – IQVIA ### 1063298###Speaker###Category Lead, Safety Evidence for Regulators###IQVIA###
Speaker: Emily W. Bratton, MSPH, PhD (she/her/hers) – IQVIA
### she/her/hers @@@ Peter GM Mol, PhD PharmD – Dutch Medicines Evaluation Board ### 1659255###Speaker###Professor of drug regulatory science###Dutch Medicines Evaluation Board###
Speaker: Peter GM Mol, PhD PharmD – Dutch Medicines Evaluation Board
### @@@ Quazi Ataher, MHS, MBBS, PhD – CSL Behring, King of Prussia, PA, USA ### 1089193###Speaker###Head of Clinical Epidemiology###CSL Behring, King of Prussia, PA, USA###
Speaker: Quazi Ataher, MHS, MBBS, PhD – CSL Behring, King of Prussia, PA, USA
### @@@ Rosa Gini, PhD (she/her/hers) – ARS Toscana, Florence, Italy ### 1302758###Speaker###Head of Unit at ARS Toscana, Florence, Italy###ARS Toscana, Florence, Italy###
Speaker: Rosa Gini, PhD (she/her/hers) – ARS Toscana, Florence, Italy
### she/her/hers
Lightning Session 1

Marleen Van Gelder, PhD (she/her/hers) – Radboud university medical center ### 1397939###Co-Moderator###Assistant Professor###Radboud university medical center###
Co-Moderator: Marleen Van Gelder, PhD (she/her/hers) – Radboud university medical center
### she/her/hers @@@ Helga Gardarsdottir, PharmD, PhD, – Division of Pharmacoepidemiology & Clinical Pharmacology, Utrecht University ### 1061395###Co-Moderator###Associate professor###Division of Pharmacoepidemiology & Clinical Pharmacology, Utrecht University###
Co-Moderator: Helga Gardarsdottir, PharmD, PhD, – Division of Pharmacoepidemiology & Clinical Pharmacology, Utrecht University
### @@@ Lawrence Rasouliyan, MPH – OMNY Health ### 1359580###Co-Moderator###Head, Biostatistics & Data Science###OMNY Health###
Co-Moderator: Lawrence Rasouliyan, MPH – OMNY Health
### @@@ Christopher T. Rentsch, PhD, MPH – London School of Hygiene & Tropical Medicine ### 1062599###Co-Moderator###Assistant Professor###London School of Hygiene & Tropical Medicine###
Co-Moderator: Christopher T. Rentsch, PhD, MPH – London School of Hygiene & Tropical Medicine
###
Lightning Session 2

Jessica Jalbert, PhD (she/her/hers) – Regeneron ### 2015396###Co-Moderator###Executive Director - HEOR-Epidemiology###Regeneron###
Co-Moderator: Jessica Jalbert, PhD (she/her/hers) – Regeneron
### she/her/hers @@@ Robert W. Platt, PhD (he/him/his) – Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada ### 1358167###Co-Moderator###Professor###Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada###
Co-Moderator: Robert W. Platt, PhD (he/him/his) – Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada
### he/him/his @@@ Mary Beth E. Ritchey, PhD, FISPE – Food and Drug Administration ### 1991506###Co-Moderator######Food and Drug Administration###
Co-Moderator: Mary Beth E. Ritchey, PhD, FISPE – Food and Drug Administration
### @@@ Leo J. Russo, PhD – Pfizer ### 1658914###Co-Moderator###VP, Global Medical Epidemiology###Pfizer###
Co-Moderator: Leo J. Russo, PhD – Pfizer
###
Lightning Session 3

J. Bradley Layton, PhD, FISPE (he/him/his) – RTI Health Solutions ### 1062745###Co-Moderator###Director, Epidemiology###RTI Health Solutions###
Co-Moderator: J. Bradley Layton, PhD, FISPE (he/him/his) – RTI Health Solutions
### he/him/his @@@ Kourtney Davis, PhD MSPH FISPE (she/her/hers) – Janssen Research & Development ### 1292361###Co-Moderator###Vice President###Janssen Research & Development###
Co-Moderator: Kourtney Davis, PhD MSPH FISPE (she/her/hers) – Janssen Research & Development
### she/her/hers @@@ Rachel E. Sobel, DrPH, FISPE (she/her/hers) – Regeneron Pharmaceuticals, Inc. ### 1991877###Co-Moderator###Executive Director, Head of Pharmacoepidemiology###Regeneron Pharmaceuticals, Inc.###
Co-Moderator: Rachel E. Sobel, DrPH, FISPE (she/her/hers) – Regeneron Pharmaceuticals, Inc.
### she/her/hers @@@ Lisa G. Pont, PhD – Discipline of Pharmacy, University of Technology Sydney, Sydney, NSW, Australia ### 1655255###Co-Moderator###Professor of Pharmacy###Discipline of Pharmacy, University of Technology Sydney, Sydney, NSW, Australia###
Co-Moderator: Lisa G. Pont, PhD – Discipline of Pharmacy, University of Technology Sydney, Sydney, NSW, Australia
###
Likelihood of Antimicrobial Resistance in Urinary E. coli Isolates Comparing Female Patients with Recurrent Versus Non-recurrent Uncomplicated Urinary Tract Infection in the United States

Debra Fromer – Hackensack University Medical Center, Hackensack, NJ, USA ### 1991194###Co-Author######Hackensack University Medical Center, Hackensack, NJ, USA###
Co-Author: Debra Fromer – Hackensack University Medical Center, Hackensack, NJ, USA
### @@@ Wendy Y. Cheng, PhD, MPH – Analysis Group, Inc. ### 1991195###Co-Author######Analysis Group, Inc.###
Co-Author: Wendy Y. Cheng, PhD, MPH – Analysis Group, Inc.
### @@@ Chi Gao, MS, ScD – Analysis Group, Inc., Boston, MA, USA ### 1991196###Co-Author######Analysis Group, Inc., Boston, MA, USA###
Co-Author: Chi Gao, MS, ScD – Analysis Group, Inc., Boston, MA, USA
### @@@ Malena Mahendran, MSc – Analysis Group, Inc., Boston, MA, USA ### 1991197###Co-Author######Analysis Group, Inc., Boston, MA, USA###
Co-Author: Malena Mahendran, MSc – Analysis Group, Inc., Boston, MA, USA
### @@@ Annalise Hilts – Analysis Group, Inc., Boston, MA, USA ### 1991198###Co-Author######Analysis Group, Inc., Boston, MA, USA###
Co-Author: Annalise Hilts – Analysis Group, Inc., Boston, MA, USA
### @@@ Mei Sheng Duh, MPH, ScD (she/her/hers) – Analysis Group, Inc., Boston, MA, USA ### 1359083###Presenting Author###Chief Epidemiologist and Managing Principal###Analysis Group, Inc., Boston, MA, USA###
Presenting Author: Mei Sheng Duh, MPH, ScD (she/her/hers) – Analysis Group, Inc., Boston, MA, USA
### she/her/hers @@@ Ashish V. Joshi, PhD – GSK, Collegeville, PA, USA ### 1991199###Co-Author######GSK, Collegeville, PA, USA###
Co-Author: Ashish V. Joshi, PhD – GSK, Collegeville, PA, USA
### @@@ Aruni Mulgirigama – GSK, Surrey, UK ### 1991200###Co-Author######GSK, Surrey, UK###
Co-Author: Aruni Mulgirigama – GSK, Surrey, UK
### @@@ Fanny S. Mitrani-Gold, MPH (she/her/hers) – GSK ### 1991193###Co-Author###Director of Epidemiology, Infectious Diseases###GSK###
Co-Author: Fanny S. Mitrani-Gold, MPH (she/her/hers) – GSK
### she/her/hers
Lithium in Pregnancy: A Utilization Study in the Five Nordic Countries

Felix Wittström, MD – Centre for Pharmacoepidemiology, Karolinska Institutet ### 1991251###Presenting Author###PhD-student###Centre for Pharmacoepidemiology, Karolinska Institutet###
Presenting Author: Felix Wittström, MD – Centre for Pharmacoepidemiology, Karolinska Institutet
### @@@ Carolyn E. Cesta, PhD – Centre for Pharmacoepidemiology, Karolinska Institutet ### 1062759###Co-Author###Researcher###Centre for Pharmacoepidemiology, Karolinska Institutet###
Co-Author: Carolyn E. Cesta, PhD – Centre for Pharmacoepidemiology, Karolinska Institutet
### @@@ Jacqueline M. Cohen, PhD (she/her/hers) – Department of Chronic Diseases & Centre for Fertility and Health, Norwegian Institute of Public Health ### 1360547###Co-Author###Senior Researcher###Department of Chronic Diseases & Centre for Fertility and Health, Norwegian Institute of Public Health###
Co-Author: Jacqueline M. Cohen, PhD (she/her/hers) – Department of Chronic Diseases & Centre for Fertility and Health, Norwegian Institute of Public Health
### she/her/hers @@@ Marie Bendix – Karolinska Institutet ### 1991302###Co-Author######Karolinska Institutet###
Co-Author: Marie Bendix – Karolinska Institutet
### @@@ Mette Bliddal, PhD – University of Southern Denmark ### 1062809###Co-Author###Associate professor###University of Southern Denmark###
Co-Author: Mette Bliddal, PhD – University of Southern Denmark
### @@@ Mika Gissler, PhD – Department of Knowledge Brokers, Finnish Institute for Health and Welfare, Helsinki ### 1360036###Co-Author###Professor###Department of Knowledge Brokers, Finnish Institute for Health and Welfare, Helsinki###
Co-Author: Mika Gissler, PhD – Department of Knowledge Brokers, Finnish Institute for Health and Welfare, Helsinki
### @@@ Maarit K. Leinonen, MD, PhD – Data and Analytics, Knowledge Brokers, Finnish Institute for Health and Welfare, Helsinki, Finland ### 1358190###Co-Author###Associate professor###Data and Analytics, Knowledge Brokers, Finnish Institute for Health and Welfare, Helsinki, Finland###
Co-Author: Maarit K. Leinonen, MD, PhD – Data and Analytics, Knowledge Brokers, Finnish Institute for Health and Welfare, Helsinki, Finland
### @@@ Laura Pazzagli, PhD – Clinical Epidemiology Division, Karolinska Institutet ### 1358376###Co-Author######Clinical Epidemiology Division, Karolinska Institutet###
Co-Author: Laura Pazzagli, PhD – Clinical Epidemiology Division, Karolinska Institutet
### @@@ Lotte Rasmussen, MScPharm, PhD – Syddansk Universitet ### 1358115###Co-Author###Assistant professor###Syddansk Universitet###
Co-Author: Lotte Rasmussen, MScPharm, PhD – Syddansk Universitet
### @@@ Helga Zoega – University of New South Wales - Sydney ### 1358124###Co-Author###Associate professor/professor###University of New South Wales - Sydney###
Co-Author: Helga Zoega – University of New South Wales - Sydney
### @@@ Johan Reutfors, MD, PhD – Centre for Pharmacoepidemiology, Karolinska Institutet ### 1358377###Co-Author###Associate professor###Centre for Pharmacoepidemiology, Karolinska Institutet###
Co-Author: Johan Reutfors, MD, PhD – Centre for Pharmacoepidemiology, Karolinska Institutet
###
Liver and Pregnancy Research Gone Viral

Emily S. Brouwer, PhD – University of Kentucky College of Pharmacy ### 1360358###Co-Moderator######University of Kentucky College of Pharmacy###
Co-Moderator: Emily S. Brouwer, PhD – University of Kentucky College of Pharmacy
### @@@ Anick Bérard, PhD, FISPE (she/her/hers) – University of Montreal ### 1302804###Co-Moderator###Professor Researcher###University of Montreal###
Co-Moderator: Anick Bérard, PhD, FISPE (she/her/hers) – University of Montreal
### she/her/hers
Longitudinal associations between body mass index and disease activity, and radiographic progression in rheumatoid arthritis patients receiving infliximab

Theresa Burkard, PhD (she/her/hers) – ETH Zurich ### 1993259###Presenting Author###Postdoctoral Data Scientist###ETH Zurich###
Presenting Author: Theresa Burkard, PhD (she/her/hers) – ETH Zurich
### she/her/hers @@@ Enriqueta Vallejo-Yagüe – ETH Zurich ### 1085673###Co-Author###PhD Candidate###ETH Zurich###
Co-Author: Enriqueta Vallejo-Yagüe – ETH Zurich
### @@@ Kim Lauper – Geneva University Hospitals ### 1993260###Co-Author######Geneva University Hospitals###
Co-Author: Kim Lauper – Geneva University Hospitals
### @@@ Axel Finckh – Geneva University Hospitals ### 1358408###Co-Author######Geneva University Hospitals###
Co-Author: Axel Finckh – Geneva University Hospitals
### @@@ Thomas Hügle, PhD – Lausanne University Hospital ### 1358769###Co-Author######Lausanne University Hospital###
Co-Author: Thomas Hügle, PhD – Lausanne University Hospital
### @@@ Andrea M. Burden, PhD – Institute of Pharmaceutical Sciences, Swiss Federal Institute of Technology, ETH Zurich, Zurich, Switzerland ### 1358409###Co-Author###Assistant Professor###Institute of Pharmaceutical Sciences, Swiss Federal Institute of Technology, ETH Zurich, Zurich, Switzerland###
Co-Author: Andrea M. Burden, PhD – Institute of Pharmaceutical Sciences, Swiss Federal Institute of Technology, ETH Zurich, Zurich, Switzerland
###
Long-term effects of intra-articular corticosteroid injections among knee osteoarthritis patients: an instrumental variable and propensity score analysis

Samuel Hawley, DPhil, MSc – University of Bristol ### 1991574###Presenting Author###Research Fellow###University of Bristol###
Presenting Author: Samuel Hawley, DPhil, MSc – University of Bristol
### @@@ Albert Prats-Uribe, MD, MPH, PhD, FFPH – Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford ### 1360474###Co-Author###Senior Researcher in Public Health and Epidemiology###Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford###
Co-Author: Albert Prats-Uribe, MD, MPH, PhD, FFPH – Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford
### @@@ Gulraj Matharu – University of Bristol ### 1991571###Co-Author######University of Bristol###
Co-Author: Gulraj Matharu – University of Bristol
### @@@ Antonella Delmestri, PhD (she/her/hers) – Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford ### 1358614###Co-Author###Lead Health Data Scientist###Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford###
Co-Author: Antonella Delmestri, PhD (she/her/hers) – Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford
### she/her/hers @@@ Daniel Prieto-Alhambra, MD MSc(Oxon) PhD (he/him/his) – University of Oxford, Erasmus MC University ### 1062615###Co-Author###Professor of Pharmaco- and Device Epidemiology, Professor of RWE###University of Oxford, Erasmus MC University###
Co-Author: Daniel Prieto-Alhambra, MD MSc(Oxon) PhD (he/him/his) – University of Oxford, Erasmus MC University
### he/him/his @@@ Andrew Judge – University of Bristol ### 1991572###Co-Author######University of Bristol###
Co-Author: Andrew Judge – University of Bristol
### @@@ Michael Whitehouse – University of Bristol ### 1991573###Co-Author######University of Bristol###
Co-Author: Michael Whitehouse – University of Bristol
###